As CEO of Awanui Group, Anoop Singh looks after one of the most important institutions in New Zealand’s laboratory medicine ecosystem. In this Q&A with Wing Lam Wong, General Manager of Roche Diagnostics New Zealand, Singh introduces his organisation and discusses how partnerships with IVD suppliers, community groups, governmental entities and other key stakeholders are integral to the services that Awanui Group provides across the care continuum in New Zealand.

This is part 1 of 2 in a Q&A series with Mr Singh. You can click here for part 2.